Deborah A Venesy, MD | |
9500 Euclid Ave, Cleveland, OH 44195-0001 | |
(800) 223-2273 | |
Not Available |
Full Name | Deborah A Venesy |
---|---|
Gender | Female |
Speciality | Physical Medicine And Rehabilitation |
Experience | 38 Years |
Location | 9500 Euclid Ave, Cleveland, Ohio |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457316911 | NPI | - | NPPES |
0788901 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 35055429V (Ohio) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Cleveland Clinic | Cleveland, OH | Hospital |
Hillcrest Hospital | Mayfield heights, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cleveland Clinic Foundation | 1850203555 | 5690 |
Menorah Park Center For Senior Living | 3577469444 | 187 |
News Archive
Par Pharmaceutical Companies, Inc. today announced that it began shipping all strengths of modafinil tablets, a generic version of Teva's Provigil brand.
Personalized medicine in lung cancer relies on the identification and characterization of cancer biomarkers and the availability of accurate detection systems and therapies for those biomarkers.
In a study recently published in the leading journal "Blood", Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and the dispensary of Vienna General Hospital, provided preliminary data on the incidence, risk factors and clinical outcomes of thrombotic complications in this new form of cancer treatment.
Researchers at The University of Texas M. D. Anderson Cancer Center are describing an entirely new way by which cells can become cancerous. And they say their finding provides an answer to a mystery in lung and other cancers.
› Verified 8 days ago
Entity Name | The Cleveland Clinic Foundation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
Par Pharmaceutical Companies, Inc. today announced that it began shipping all strengths of modafinil tablets, a generic version of Teva's Provigil brand.
Personalized medicine in lung cancer relies on the identification and characterization of cancer biomarkers and the availability of accurate detection systems and therapies for those biomarkers.
In a study recently published in the leading journal "Blood", Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and the dispensary of Vienna General Hospital, provided preliminary data on the incidence, risk factors and clinical outcomes of thrombotic complications in this new form of cancer treatment.
Researchers at The University of Texas M. D. Anderson Cancer Center are describing an entirely new way by which cells can become cancerous. And they say their finding provides an answer to a mystery in lung and other cancers.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Deborah A Venesy, MD 6000 W Creek Rd, Suite 10, Independence, OH 44131-2139 Ph: (800) 223-2273 | Deborah A Venesy, MD 9500 Euclid Ave, Cleveland, OH 44195-0001 Ph: (800) 223-2273 |
News Archive
Par Pharmaceutical Companies, Inc. today announced that it began shipping all strengths of modafinil tablets, a generic version of Teva's Provigil brand.
Personalized medicine in lung cancer relies on the identification and characterization of cancer biomarkers and the availability of accurate detection systems and therapies for those biomarkers.
In a study recently published in the leading journal "Blood", Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and the dispensary of Vienna General Hospital, provided preliminary data on the incidence, risk factors and clinical outcomes of thrombotic complications in this new form of cancer treatment.
Researchers at The University of Texas M. D. Anderson Cancer Center are describing an entirely new way by which cells can become cancerous. And they say their finding provides an answer to a mystery in lung and other cancers.
› Verified 8 days ago
Dr. Sultan Zaidan, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 18780 Bagley Rd # 100, Cleveland, OH 44130 Phone: 440-816-2850 Fax: 440-816-2855 | |
Dr. Robert Edwin Moore, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-3207 | |
Michael P Schaefer, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: Cleveland Clinic Foundation Orthopedics A40, 9500 Euclid Avenue, Cleveland, OH 44195 Phone: 216-444-0851 | |
Dr. Renae R Fisher, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 10701 East Blvd, Cleveland, OH 44106 Phone: 216-791-3800 | |
Devon Brooke Mclennan, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Marzena M Buzanowska, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Desk S40, Cleveland, OH 44195 Phone: 216-444-6077 | |
Dr. Jack E Kelly, PT, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 10701 East Blvd, Cleveland, OH 44106 Phone: 216-791-3800 |